Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues

Ophthalmic Research

Volumn 36, Issue 6, 2004, Pages 312-320

  Savaskan, Egemen ^a   Löffler, Karin U ^c   Meier, Fides ^a   Müller Spahn, Franz ^a   Flammer, Josef ^b   Meyer, Peter ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY EYE CLINIC   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Angiotensin II; Angiotensin converting enzyme; AT1 receptor; Retina

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CHOROID VASCULARIZATION; CILIARY BODY EPITHELIUM; CONJUNCTIVA; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA BIPOLAR GANGLION CELL; RETINA CELL; STAINING; TRABECULAR MESHWORK;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANGIOTENSIN II; EYE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TISSUE DISTRIBUTION;

EID: 11244316280     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081633     Document Type: Article

References (45)

1. Arregui A, Perry EK, Rossor M, Tomlinson BE: Angiotensin converting enzyme in Alzheimer's disease: Increased activity in caudate nucleus, and cortical areas. J Neurochem 1982;35:1490-1492.
2. Wright JW, Harding JW: Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev 1997;25:96-124.
3. Gard PR: The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 2002;438:1-14.
4. Fischer-Ferraro C, Nahmod VE, Goldstein DJ, Finkielman S: Angiotensin and renin in rat and dog brain. J Exp Med 1971;133:353-361.
5. Ganten D, Marquez-Julio A, Granger P, Hayduk K, Karsunky KP, Boucher R, Genest J: Renin in dog brain. Am J Physiol 1971;221:1733-1737.
6. Ganten D, Minnich JL, Granger P, Hayduk K, Brecht HM, Barbeau A, Boucher R, Genest J: Angiotensin-forming enzyme in brain tissue. Science 1971;173:64-65.
7. Ganten D, Printz M, Phillips MI, Scholkens BA: The Renin-Angiotensin System in the Brain. Berlin, Springer, 1982.
8. Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Hulette C, Müller-Spahn F: Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 2001;22:541-546.
9. Savaskan E, Höchli M, Ganten D, Chan-Palay V: Angiotensin II immunoreactivity in the human striatum and hippocampus of elderly controls and patients with senile dementia of the Alzheimer type and multi-infarct dementia. Dement Geriatr Cogn Disord 1991;2:314-323.
10. Fuxe K, Ganten D, Hökfelt T, Bolme P: Immunohistochemical evidence for the existence of angiotensin II-containing nerve terminals in the brain and spinal cord in the rat. Neurosci Lett 1976;2:229-234.
11. Weyhenmeyer JA, Phillips MI: Angiotensinlike peptide in the brain of the spontaneously hypertensive rat. Hypertension 1982;4:514-523.
12. Lind RW, Swanson LW, Ganten D: Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. Neuroendocrinology 1985;40:2-24.
13. Phillips MI, Quinlan JT, Weyhenmeyer J: An angiotensin-like peptide in the brain. Life Sci 1980;27:2589-2594.
14. Bottari SP, de Gasparo M, Steckelings UM, Levens NR: Angiotensin II receptor subtypes: Characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol 1993;14:123-171.
15. Dzau VJ: Molecular biology of angiotensin II biosynthesis and receptors. Can J Cardiol 1995;11:21F-26F.
16. Jurklies B, Eckstein A, Jacobi P, Kohler K, Risler T, Zrenner E: The renin-angiotensin system - A possible neuromodulator in the human retina? Ger J Ophthalmol 1995;4:144-150.
17. Wagner J, Jan Danser AH, Derkx FHM, de Jong PTVM, Paul M, Mullins JJ, Schalekamp MADH, Ganten D: Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996;80:159-163.
18. Murata M, Nakagawa M, Takahashi S: Angiotensinogen mRNA is synthesized locally in rat ocular tissues. Ophthalmologica 1997;211:301-304.
19. Kohler K, Wheeler-Schilling T, Jurklies B, Guenther E, Zrenner E: Angiotensin II in the rabbit retina. Vis Neurosci 1997;14:63-71.
20. Wheeler-Schilling TH, Sautter M, Guenther E, Kohler K: Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina. Exp Eye Res 2001;72:173-182.
21. Murata M, Nakagawa M, Takahashi S: Expression and localization of angiotensin II type 1 receptor mRNA in rat ocular tissues. Ophthalmologica 1997;211:384-386.
22. Wheeler-Schilling TH, Kohler K, Sautter M, Guenther E: Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat. Eur J Neurosci 1999;11:3387-3394.
23. Meyer P, Flammer J, Lüscher TF: Local action of the renin angiotensin system in the porcine ophthalmic circulation: Effects of ACE inhibitors and angiotensin receptor antagonists. Invest Ophthalmol Vis Sci 1995;36:555-562.
24. Amouyel P, Richard F, Berr C, David-Fromentin I, Helbecque N: The renin angiotensin system and Alzheimer's disease. Ann NY Acad Sci 2000;903:437-441.
25. Skoog I: Vascular aspects in Alzheimer's disease. J Neural Transm 2000;59:37-43.
26. Barnes NM, Cheng CHK, Costall B, Nylor RJ, Williams TJ, Wischik CM: Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Eur J Pharmacol 1991;200:289-292.
27. Zubenko GS, Marquis JK, Volicer L, Direnfeld LK, Langlais PJ, Nixon RA: Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: A correlative study. Biol Psychiatry 1986;21:1365-1381.
28. Crawford F, Abdullah L, Schinka J, Suo Z, Gold M, Duara R, Mullan M: Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 2000;280:215-219.
29. Isbir T, Agaçhan B, Yilmaz H, Aydin M: Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. Cell Biochem Funct 2000;18:141-142.
30. Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kräuchi K, Brydon L, Jockers R, Müller-Spahn F, Meyer P: Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Neurochem 2002;50:519-525.
31. Falkenhahn M, Franke F, Bohle RM, Zhu Y-C, Stauss HM, Bachmann S, Danilov S, Unger T: Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 1995;25:219-226.
32. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995;375:247-250.
33. Spencer WH: Ophthalmic Pathology, ed 4. Philadelphia, Saunders, 1996.
34. Lind RW, Ganten D: Angiotensin; in Björklund A, Hökfelt T, Kuhar MJ (eds): Handbook of Chemical Neuroanatomy. New York, Elsevier Science Publishers, 1990, vol 9: Neuropeptides in the CNS, pp 165-286.
35. Danser AH, Derkx FH, Admiraal PJ, Deinum J, de Jong PT, Schalekamp MA: Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994;35:1008-1018.
36. Deinum J, Derkx FHM, Danser AHJ, Schalekamp MADH: Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990;126:1673-1682.
37. Costagliola C, Di Benedetto R, De Caprio L, Verde R, Mastropasqua L: Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol 1995;5:19-25.
38. Sjolie AK, Chaturvedi N: The retinal reninangiotensin system: Implications for therapy in diabetic retinopathy. J Hum Hypertens 2002;16:S42-S46.
39. Lutjen-Drecoll E: Functional morphology of the ciliary epithelium; in Lutjen-Drecoll E (ed): Basic Aspects of Glaucoma Research. Stuttgart, Schattauer, 1982.
40. Datum KH, Zrenner E: Angiotensin-like immunoreactive cells in the chicken retina. Exp Eye Res 1991;53:157-165.
41. Britto LR, Hamassaki DE, Keyser KT, Karten HJ: Neurotransmitters, receptors, and neuropeptides in the accessory optic system: An immunohistochemical survey in the pigeon (Columba livia). Vis Neurosci 1989;3:463-475.
42. Terman M, Remé CE, Wirz-Justice A: The visual input stage of the mammalian circadian pacemaking system. II. The effect of light and drugs on retinal function. J Biol Rhythms 1991;6:31-48.
43. Abrahamson EE, Moore RY: Suprachiasmatic neucleus in the mouse: Retinal innervation, intrinsic organization and efferent projections. Brain Res 2001;916:172-191.
44. Guenther E, Schmid S, Hewig B, Kohler K: Two-fold effect of angiotensin II on voltagedependent calcium currents in rat retinal ganglion cells. Brain Res 1996;718:112-116.
45. Otani A, Takagi H, Oh H, Koyama S, Honda Y: Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001;50:867-875.